Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 7 | 2012 | 106 | 1.740 |
Why?
|
| Medulla Oblongata | 7 | 2007 | 40 | 1.310 |
Why?
|
| Pancoast Syndrome | 1 | 2022 | 1 | 0.840 |
Why?
|
| Nicotinic Agonists | 2 | 2014 | 75 | 0.810 |
Why?
|
| Taste | 2 | 2012 | 41 | 0.770 |
Why?
|
| Brain Stem | 3 | 2012 | 50 | 0.770 |
Why?
|
| Nicotine | 3 | 2014 | 257 | 0.750 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 88 | 0.750 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1015 | 0.610 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 358 | 0.610 |
Why?
|
| Neurons | 4 | 2012 | 1175 | 0.600 |
Why?
|
| Afferent Pathways | 2 | 2014 | 37 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2012 | 86 | 0.490 |
Why?
|
| Motor Neurons | 2 | 2005 | 83 | 0.480 |
Why?
|
| Respiration | 4 | 2001 | 58 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2012 | 1618 | 0.440 |
Why?
|
| Signal Transduction | 2 | 2012 | 1908 | 0.410 |
Why?
|
| Rats | 12 | 2012 | 3483 | 0.370 |
Why?
|
| Epithelial Cells | 3 | 2012 | 384 | 0.370 |
Why?
|
| Cocaine | 3 | 2001 | 232 | 0.360 |
Why?
|
| Respiratory Mucosa | 1 | 2010 | 43 | 0.350 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2009 | 3 | 0.350 |
Why?
|
| Nociceptors | 1 | 2009 | 32 | 0.340 |
Why?
|
| Substance P | 1 | 2009 | 26 | 0.340 |
Why?
|
| Hemodynamics | 2 | 2001 | 91 | 0.330 |
Why?
|
| Pons | 1 | 2007 | 9 | 0.310 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2007 | 79 | 0.300 |
Why?
|
| Brain | 2 | 2014 | 1346 | 0.290 |
Why?
|
| Animals | 18 | 2014 | 15081 | 0.280 |
Why?
|
| Spinal Cord | 2 | 2004 | 94 | 0.280 |
Why?
|
| Vagus Nerve | 1 | 2006 | 20 | 0.280 |
Why?
|
| Lung | 1 | 2009 | 446 | 0.270 |
Why?
|
| Bronchi | 1 | 2006 | 46 | 0.270 |
Why?
|
| Protein Subunits | 1 | 2006 | 87 | 0.270 |
Why?
|
| Hypoglossal Nerve | 1 | 2005 | 10 | 0.260 |
Why?
|
| Cell Count | 3 | 2014 | 135 | 0.260 |
Why?
|
| Inhalation | 1 | 2004 | 8 | 0.250 |
Why?
|
| Diaphragm | 1 | 2004 | 11 | 0.250 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 282 | 0.210 |
Why?
|
| Shoulder Pain | 1 | 2022 | 2 | 0.210 |
Why?
|
| Atropine | 1 | 2001 | 13 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 214 | 0.190 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 893 | 0.190 |
Why?
|
| Male | 13 | 2022 | 20025 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2014 | 82 | 0.170 |
Why?
|
| Respiratory System | 2 | 2012 | 28 | 0.160 |
Why?
|
| Fluorocarbons | 2 | 1995 | 26 | 0.160 |
Why?
|
| Hemoglobins | 2 | 1995 | 107 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 3 | 1995 | 139 | 0.150 |
Why?
|
| Kidney | 3 | 1995 | 337 | 0.150 |
Why?
|
| Acetylcholine | 2 | 2006 | 73 | 0.150 |
Why?
|
| Cats | 4 | 2001 | 69 | 0.140 |
Why?
|
| Procaine | 1 | 1996 | 3 | 0.140 |
Why?
|
| Prazosin | 1 | 1996 | 11 | 0.140 |
Why?
|
| Propranolol | 1 | 1996 | 18 | 0.140 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 31 | 0.140 |
Why?
|
| Narcotics | 1 | 1996 | 32 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1996 | 52 | 0.130 |
Why?
|
| Cholera Toxin | 2 | 2006 | 39 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2012 | 1207 | 0.130 |
Why?
|
| Blood Pressure | 3 | 1994 | 646 | 0.120 |
Why?
|
| Physostigmine | 1 | 1994 | 1 | 0.120 |
Why?
|
| Carbachol | 1 | 1994 | 19 | 0.120 |
Why?
|
| Caffeine | 1 | 1994 | 28 | 0.120 |
Why?
|
| Vasomotor System | 1 | 1993 | 4 | 0.110 |
Why?
|
| Respiratory Center | 1 | 1993 | 12 | 0.110 |
Why?
|
| Taste Buds | 1 | 2012 | 3 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 1993 | 29 | 0.110 |
Why?
|
| Receptors, Purinergic | 1 | 2012 | 4 | 0.110 |
Why?
|
| Autocrine Communication | 1 | 2012 | 12 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2012 | 15 | 0.100 |
Why?
|
| Nitric Oxide Synthase | 1 | 2012 | 128 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1039 | 0.100 |
Why?
|
| Smoking | 2 | 2010 | 940 | 0.100 |
Why?
|
| Transducin | 1 | 2010 | 1 | 0.090 |
Why?
|
| Phospholipase C beta | 1 | 2010 | 2 | 0.090 |
Why?
|
| Middle Aged | 4 | 2022 | 10129 | 0.090 |
Why?
|
| Renal Circulation | 1 | 1989 | 21 | 0.080 |
Why?
|
| Indomethacin | 1 | 1989 | 28 | 0.080 |
Why?
|
| Sensory Receptor Cells | 1 | 2009 | 32 | 0.080 |
Why?
|
| Calcium Channel Blockers | 1 | 1989 | 56 | 0.080 |
Why?
|
| Spinal Cord Compression | 2 | 2000 | 6 | 0.080 |
Why?
|
| Decompression, Surgical | 2 | 2000 | 7 | 0.080 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2000 | 9 | 0.080 |
Why?
|
| Gene Expression | 2 | 2009 | 674 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2007 | 19 | 0.080 |
Why?
|
| Parvalbumins | 1 | 2007 | 16 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 623 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 78 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2009 | 859 | 0.070 |
Why?
|
| Bronchoconstriction | 1 | 2006 | 1 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2006 | 10 | 0.070 |
Why?
|
| Trachea | 1 | 2006 | 25 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 146 | 0.060 |
Why?
|
| Respiratory Muscles | 1 | 2004 | 10 | 0.060 |
Why?
|
| Phrenic Nerve | 1 | 2004 | 18 | 0.060 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2004 | 25 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2004 | 207 | 0.060 |
Why?
|
| Mice | 1 | 2014 | 5913 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2010 | 517 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2001 | 18 | 0.050 |
Why?
|
| Chemoreceptor Cells | 1 | 2001 | 20 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2001 | 177 | 0.050 |
Why?
|
| Median Nerve | 2 | 2000 | 6 | 0.050 |
Why?
|
| Humans | 4 | 2022 | 37093 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 2000 | 20 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 364 | 0.040 |
Why?
|
| Morphine Derivatives | 1 | 1999 | 2 | 0.040 |
Why?
|
| Perfusion | 2 | 1995 | 33 | 0.040 |
Why?
|
| Morphine | 1 | 1999 | 85 | 0.040 |
Why?
|
| Methionine | 1 | 1998 | 30 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1998 | 23 | 0.040 |
Why?
|
| Arginine | 1 | 1998 | 73 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 1999 | 197 | 0.040 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 3 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 1995 | 2 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 1996 | 64 | 0.030 |
Why?
|
| Tidal Volume | 1 | 1994 | 10 | 0.030 |
Why?
|
| Blood Substitutes | 1 | 1994 | 4 | 0.030 |
Why?
|
| Female | 6 | 2000 | 20969 | 0.030 |
Why?
|
| Heart Arrest | 1 | 1994 | 35 | 0.030 |
Why?
|
| Administration, Topical | 1 | 1993 | 40 | 0.030 |
Why?
|
| Time Factors | 2 | 1994 | 1742 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 130 | 0.030 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 52 | 0.020 |
Why?
|
| Heart Rate | 1 | 1993 | 253 | 0.020 |
Why?
|
| Diet | 1 | 1998 | 801 | 0.020 |
Why?
|
| Diltiazem | 1 | 1989 | 5 | 0.020 |
Why?
|
| Verapamil | 1 | 1989 | 7 | 0.020 |
Why?
|
| Bucladesine | 1 | 1989 | 8 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 1989 | 29 | 0.020 |
Why?
|
| Renin | 1 | 1989 | 30 | 0.020 |
Why?
|
| Sodium | 1 | 1989 | 103 | 0.020 |
Why?
|
| Dogs | 1 | 1989 | 149 | 0.020 |
Why?
|
| Cervical Vertebrae | 2 | 2000 | 15 | 0.020 |
Why?
|
| Kinetics | 1 | 1989 | 708 | 0.020 |
Why?
|
| Calcium | 1 | 1989 | 480 | 0.020 |
Why?
|
| Aged | 3 | 2000 | 6741 | 0.010 |
Why?
|
| Reflex | 1 | 2000 | 34 | 0.010 |
Why?
|
| Gait | 1 | 2000 | 25 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 136 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2000 | 225 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1999 | 13 | 0.010 |
Why?
|
| Adult | 3 | 2000 | 11712 | 0.010 |
Why?
|
| Rats, Inbred ACI | 1 | 1998 | 11 | 0.010 |
Why?
|
| Cachexia | 1 | 1998 | 6 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1998 | 122 | 0.010 |
Why?
|
| Disease Progression | 1 | 2000 | 601 | 0.010 |
Why?
|
| Weight Gain | 1 | 1998 | 136 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2000 | 481 | 0.010 |
Why?
|
| Spinal Osteophytosis | 1 | 1996 | 1 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 1996 | 3 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1996 | 10 | 0.010 |
Why?
|
| Quadriplegia | 1 | 1996 | 5 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1996 | 30 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 1996 | 24 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2000 | 1369 | 0.010 |
Why?
|
| Reaction Time | 1 | 1996 | 143 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1996 | 210 | 0.010 |
Why?
|
| Urine | 1 | 1994 | 13 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1994 | 98 | 0.010 |
Why?
|
| Prognosis | 1 | 1996 | 739 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1999 | 2379 | 0.010 |
Why?
|